
Meredith A. Long
Examiner (ID: 9614)
| Most Active Art Unit | 3688 |
| Art Unit(s) | 3622, 3688 |
| Total Applications | 451 |
| Issued Applications | 174 |
| Pending Applications | 56 |
| Abandoned Applications | 228 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19954422
[patent_doc_number] => 12324819
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-10
[patent_title] => Composition containing
[patent_app_type] => utility
[patent_app_number] => 17/616088
[patent_app_country] => US
[patent_app_date] => 2020-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 2847
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17616088
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/616088 | Composition containing | Oct 20, 2020 | Issued |
Array
(
[id] => 19011793
[patent_doc_number] => 11918694
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-05
[patent_title] => Orally ingestible delivery system
[patent_app_type] => utility
[patent_app_number] => 17/075030
[patent_app_country] => US
[patent_app_date] => 2020-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 58779
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 284
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17075030
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/075030 | Orally ingestible delivery system | Oct 19, 2020 | Issued |
Array
(
[id] => 16778405
[patent_doc_number] => 20210115483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => Transparent Cellulose-Based Materials and Methods of Making the Same
[patent_app_type] => utility
[patent_app_number] => 17/073088
[patent_app_country] => US
[patent_app_date] => 2020-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5845
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17073088
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/073088 | Transparent Cellulose-Based Materials and Methods of Making the Same | Oct 15, 2020 | Abandoned |
Array
(
[id] => 16778338
[patent_doc_number] => 20210115416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => PEGYLATED KYNURENINASE ENZYMES AND USES THEREOF FOR THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/073030
[patent_app_country] => US
[patent_app_date] => 2020-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22796
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -102
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17073030
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/073030 | PEGYLATED KYNURENINASE ENZYMES AND USES THEREOF FOR THE TREATMENT OF CANCER | Oct 15, 2020 | Pending |
Array
(
[id] => 16762599
[patent_doc_number] => 20210108180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => ELECTROCONDUCTIVE DECELLULARIZED EXTRACELLULAR MATRIX COMPOSITIONS FOR PREPARATION OF ENGINEERED TISSUES AND RELATED METHODS
[patent_app_type] => utility
[patent_app_number] => 17/039153
[patent_app_country] => US
[patent_app_date] => 2020-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14225
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17039153
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/039153 | ELECTROCONDUCTIVE DECELLULARIZED EXTRACELLULAR MATRIX COMPOSITIONS FOR PREPARATION OF ENGINEERED TISSUES AND RELATED METHODS | Sep 29, 2020 | Abandoned |
Array
(
[id] => 18005373
[patent_doc_number] => 20220364139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => METHODS FOR DETERMINING GROWTH AND RESPONSE
[patent_app_type] => utility
[patent_app_number] => 17/762332
[patent_app_country] => US
[patent_app_date] => 2020-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29657
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17762332
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/762332 | METHODS FOR DETERMINING GROWTH AND RESPONSE | Sep 23, 2020 | Abandoned |
Array
(
[id] => 16673405
[patent_doc_number] => 20210062168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => ENGINEERED LIPASE VARIANTS
[patent_app_type] => utility
[patent_app_number] => 17/005913
[patent_app_country] => US
[patent_app_date] => 2020-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41927
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -46
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17005913
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/005913 | Engineered lipase variants | Aug 27, 2020 | Issued |
Array
(
[id] => 18065694
[patent_doc_number] => 20220396781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => CYCLOHEXENECARBOXYLATE ESTER HYDROLASE, AND MUTANT, CODING GENE, EXPRESSION VECTOR, RECOMBINANT BACTERIUM AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/296218
[patent_app_country] => US
[patent_app_date] => 2020-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4742
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17296218
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/296218 | Cyclohexenecarboxylate ester hydrolase, and mutant, coding gene, expression vector, recombinant bacterium and use thereof | Jul 29, 2020 | Issued |
Array
(
[id] => 16599337
[patent_doc_number] => 20210025868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => IDENTIFICATION OF VIABLE HUMAN EMBRYOS
[patent_app_type] => utility
[patent_app_number] => 16/937692
[patent_app_country] => US
[patent_app_date] => 2020-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15157
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16937692
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/937692 | Identification of viable human embryos | Jul 23, 2020 | Issued |
Array
(
[id] => 16571047
[patent_doc_number] => 20210010053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => ASSAYS FOR IMPROVING AUTOMATED ANTIMICROBIAL SUSCEPTIBILITY TESTING ACCURACY
[patent_app_type] => utility
[patent_app_number] => 16/925719
[patent_app_country] => US
[patent_app_date] => 2020-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14136
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16925719
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/925719 | ASSAYS FOR IMPROVING AUTOMATED ANTIMICROBIAL SUSCEPTIBILITY TESTING ACCURACY | Jul 9, 2020 | Pending |
Array
(
[id] => 16576604
[patent_doc_number] => 20210011005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => SYSTEMS AND METHODS FOR EVALUATING IMMUNE RESPONSE TO INFECTION
[patent_app_type] => utility
[patent_app_number] => 16/925943
[patent_app_country] => US
[patent_app_date] => 2020-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11400
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16925943
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/925943 | SYSTEMS AND METHODS FOR EVALUATING IMMUNE RESPONSE TO INFECTION | Jul 9, 2020 | Pending |
Array
(
[id] => 18996149
[patent_doc_number] => 11912981
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-27
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 17/280891
[patent_app_country] => US
[patent_app_date] => 2020-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 2342
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17280891
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/280891 | None | Jun 17, 2020 | Issued |
Array
(
[id] => 20453311
[patent_doc_number] => 12516363
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-06
[patent_title] => Production of natural organic gluconates
[patent_app_type] => utility
[patent_app_number] => 17/432630
[patent_app_country] => US
[patent_app_date] => 2020-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 0
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17432630
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/432630 | Production of natural organic gluconates | Jun 7, 2020 | Issued |
Array
(
[id] => 17749975
[patent_doc_number] => 20220228180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => Methods for production of strictosidine aglycone and monoterpenoid indole alkaloids
[patent_app_type] => utility
[patent_app_number] => 17/610224
[patent_app_country] => US
[patent_app_date] => 2020-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39008
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17610224
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/610224 | Methods for production of strictosidine aglycone and monoterpenoid indole alkaloids | May 12, 2020 | Pending |
Array
(
[id] => 17625779
[patent_doc_number] => 20220160794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => USE OF BACILLUS AMYLOLIQUEFACIENS AND/OR BACILLUS SUBTILIS FOR THE ENHANCEMENT OF ACTIVE PROBIOTIC COMPOSITIONS OR FOR THE ACTIVATION OF INACTIVE PROBIOTIC COMPOSITIONS, COMPOSITIONS THUS OBTAINED, AND RELATED METHOD
[patent_app_type] => utility
[patent_app_number] => 17/425691
[patent_app_country] => US
[patent_app_date] => 2020-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4867
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17425691
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/425691 | USE OF BACILLUS AMYLOLIQUEFACIENS AND/OR BACILLUS SUBTILIS FOR THE ENHANCEMENT OF ACTIVE PROBIOTIC COMPOSITIONS OR FOR THE ACTIVATION OF INACTIVE PROBIOTIC COMPOSITIONS, COMPOSITIONS THUS OBTAINED, AND RELATED METHOD | Apr 28, 2020 | Pending |
Array
(
[id] => 16343941
[patent_doc_number] => 20200308591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => PROMOTER REGION ANALYSIS METHODS AND CELLS FOR PRACTICING SAME
[patent_app_type] => utility
[patent_app_number] => 16/831586
[patent_app_country] => US
[patent_app_date] => 2020-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20137
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16831586
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/831586 | PROMOTER REGION ANALYSIS METHODS AND CELLS FOR PRACTICING SAME | Mar 25, 2020 | Abandoned |
Array
(
[id] => 19808260
[patent_doc_number] => 12239619
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-04
[patent_title] => Composition for inducing pili formation in bacterium of genus
[patent_app_type] => utility
[patent_app_number] => 17/433755
[patent_app_country] => US
[patent_app_date] => 2020-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 6309
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17433755
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/433755 | Composition for inducing pili formation in bacterium of genus | Feb 27, 2020 | Issued |
Array
(
[id] => 18854120
[patent_doc_number] => 11851683
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-12-26
[patent_title] => Methods and systems for selective analysis of cellular samples
[patent_app_type] => utility
[patent_app_number] => 16/789273
[patent_app_country] => US
[patent_app_date] => 2020-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 21
[patent_no_of_words] => 35284
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16789273
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/789273 | Methods and systems for selective analysis of cellular samples | Feb 11, 2020 | Issued |
Array
(
[id] => 17480588
[patent_doc_number] => 20220088092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => COMPOSITIONS AND METHODS FOR INCREASING THE VIABILITY OF FREEZE-DRIED PROBIOTICS
[patent_app_type] => utility
[patent_app_number] => 17/424291
[patent_app_country] => US
[patent_app_date] => 2020-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14124
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17424291
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/424291 | COMPOSITIONS AND METHODS FOR INCREASING THE VIABILITY OF FREEZE-DRIED PROBIOTICS | Jan 20, 2020 | Abandoned |
Array
(
[id] => 19426159
[patent_doc_number] => 12085566
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-10
[patent_title] => Inert carrier
[patent_app_type] => utility
[patent_app_number] => 16/963079
[patent_app_country] => US
[patent_app_date] => 2020-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3712
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16963079
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/963079 | Inert carrier | Jan 12, 2020 | Issued |